Acute Pain Treatment Market Size Report 2034 | Johnson & Johnson, Eli Lilly, Pfizer, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Baxter International Inc., Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laborato

DelveInsight's "Acute Pain Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Acute Pain, historical and forecasted epidemiology as well as the Acute Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Explore the latest insights into the Acute Pain Treatment Market Size and emerging therapies! Read the full report now @ Acute Pain Market Outlook- https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Acute Pain Market Report
• In January 2025:- Latigo Biotherapeutics:- The goal of this clinical trial is to learn if LTG-001 works to treat pain after third molar removal surgery in adults. It will also learn about the safety of LTG-001. Take LTG-001 one time after the surgical removal of impacted third molars. Remain at the clinic for 12 hours after study dosing and return after a week for a safety check up.
• In January 2025:- Xgene Pharmaceutical Group- This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjects undergoing bunionectomy. Subjects will be confined in the clinic from check-in through 72 hours post-surgery to monitor subject safety.
• In January 2025:- Vertex Pharmaceuticals Incorporated:- The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
• In January 2025, Scilex Holding Company announced the submission of a Supplemental New Drug Application (SNDA) to the FDA for ELYXYB®, a liquid oral solution of celecoxib, for the treatment of acute pain in adults. This submission could provide a non-opioid alternative for acute pain management.
• The increase in Acute Pain Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Acute Pain Market is anticipated to witness growth at a considerable CAGR.
• The leading Acute Pain Companies such as Johnson & Johnson, Eli Lilly, Pfizer, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Baxter International Inc., Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories Inc., and others.
• Promising Acute Pain Pipeline Therapies such as Diclofenac Sodium Patch, Methoxyflurane, Diclofenac 50, IV Acetaminophen, VX-548, HB/APAP, and others.

Stay ahead in the Acute Pain Drugs Market! Get expert analysis on key players, trends, and clinical advancements @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Pain Overview
Acute pain is an umbrella term, but the most common symptoms associated with acute pain include fatigue, flu-like symptoms, insomnia, anxiety, burning, etc. Nociceptive pain is usually acute and develops in response to a specific situation. It disappears as the affected body part heals. For example, nociceptive pain from a broken ankle gets better as the ankle heals. Diagnosis of acute pain is made using pain assessment scales, which include VAS, VRS, NPRS, MPQ, BPI, etc. Doctors diagnose the pain by discussing symptoms, the intensity and location of pain, and the history of injury, surgery, or illness. Young patients may be asked to rate their pain intensity using the faces of the pain scale. Additional diagnostic tests might include Blood Tests, X-rays, CT scans, MRI, Ultrasounds, Dye-injection studies, and Nerve conduction studies.

Acute Pain Epidemiology Insights
The Acute Pain epidemiology chapter in the report provides historical as well as forecasted in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2024 to 2034. The Acute Pain epidemiology is segmented with detailed insights into the total incident cases, total diagnosed cases, type-specific cases, severity-specific cases, and total treated cases of acute pain.

Download the report to understand which factors are driving Acute Pain Epidemiology trends @ Acute Pain Prevalence- https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Pain Marketed Drugs

• POSIMIR (bupivacaine solution): Durect Corporation
POSIMIR (bupivacaine solution) for infiltration use is a novel and proprietary product that combines the strength of 660 mg of bupivacaine base with the innovative SABER platform technology, enabling continuous sustained delivery of a non-opioid local analgesic over 3 days in adults. POSIMIR contains more bupivacaine than any other approved single-dose sustained-release bupivacaine product. POSIMIR is administered into the subacromial space under direct arthroscopic visualization at the end of the surgery, where it continuously releases bupivacaine for 72 hours or more.

• ZYNRELEF (bupivacaine and meloxicam): Heron Therapeutics
ZYNRELEF (formerly known as HTX-011) (bupivacaine and meloxicam) is a fixed-dose combination of the local anesthetic bupivacaine with the non-steroidal anti-inflammatory drug (NSAID) meloxicam. The drug is approved in Europe, while an NDA in the US has been approved in January 2024. ZYNRELEF is indicated to treat somatic-postoperative pain from small- to medium-sized surgical wounds in adults.

Acute Pain Drugs Market
The Acute Pain Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Acute Pain signaling in Acute Pain are likely to uncover new therapeutic targets and further expand treatment options for patients.

Acute Pain Treatment Market Landscape
The Acute Pain treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Acute Pain has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To know more about Acute Pain treatment guidelines, visit @ Acute Pain Treatment Market Landscape- https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Acute Pain Market Outlook
The report's outlook on the Acute Pain market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Acute Pain therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Acute Pain drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Acute Pain market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

Acute Pain Drugs Uptake
The drug chapter of the Acute Pain report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Acute Pain.

Major Acute Pain Companies
Johnson & Johnson, Eli Lilly, Pfizer, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Baxter International Inc., Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories Inc., and others.

Which companies are leading the Acute Pain Therapeutics Market? Uncover the competitive landscape and future outlook. 🚀 Access the report here- https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Acute Pain Market Research Report
• Coverage- 7MM
• Acute Pain Companies- Johnson & Johnson, Eli Lilly, Pfizer, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Baxter International Inc., Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories Inc., and others.
• Acute Pain Therapies- Diclofenac Sodium Patch, Methoxyflurane, Diclofenac 50, IV Acetaminophen, VX-548, HB/APAP, and others.
• Acute Pain Market Dynamics: Acute Pain Market Drivers and Barriers
• Acute Pain Market Access and Reimbursement, Unmet Needs and Future Perspectives

What's driving growth in the Acute Pain Drugs Market? Explore trends, opportunities, and market forecasts. 📈 Get insights @ Acute Pain Clinical Trials Assessment- https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Report Introduction
3. Acute Pain Market Overview at a Glance
4. Executive Summary of Acute Pain
5. Key Events
6. Acute Pain Epidemiology and Market Methodology
7. Disease Background and Overview: Acute Pain
8. Acute Pain Patient Journey
9. Acute Pain Epidemiology and Patient Population
10. Marketed Acute Pain Drugs
11. Emerging Acute Pain Drugs
12. Acute Pain Market: 7MM Market Analysis
13. Acute Pain KOL Views
14. Acute Pain Unmet needs
15. Acute Pain SWOT Analysis
16. Acute Pain Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

Don't miss out on critical insights into the Acute Pain Market! Get the latest data and strategic forecasts. 📑 Download now @ https://www.delveinsight.com/sample-request/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

List of Top Selling Market Research Reports in 2025

Athlete's Foot Market- https://www.delveinsight.com/report-store/athletes-foot-market
Tuberculosis Market- https://www.delveinsight.com/report-store/tuberculosis-market
Wound Healing Devices Market- https://www.delveinsight.com/report-store/wound-healing-devices-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Complex Regional Pain Syndrome Market- https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market
Coronary Microvascular Dysfunction Market- https://www.delveinsight.com/report-store/coronary-microvascular-dysfunction-market
Diabetes Insipidus Market- https://www.delveinsight.com/report-store/diabetes-insipidus-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitor-pipeline-insight
Healthcare Competitive Benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Heart Failure Market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
Hyperphosphatemia Market- https://www.delveinsight.com/report-store/hyperphosphatemia-market
Immune Checkpoints Activators Market- https://www.delveinsight.com/report-store/immune-checkpoints-activators
Japan Healthcare Outlook Market- https://www.delveinsight.com/report-store/japan-healthcare-outlook-report
Joint Reconstruction Devices Market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Mantle Cell Lymphoma Market- https://www.delveinsight.com/report-store/mantle-cell-lymphoma-market
Methicillin-resistant Staphylococcus Aureus Infection Market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
Mouth Neoplasms Market- https://www.delveinsight.com/report-store/mouth-neoplasms-market
Myocardial Infarction Market- https://www.delveinsight.com/report-store/myocardial-infarction-market
Neuroendocrine Tumor Market- https://www.delveinsight.com/report-store/neuroendocrine-tumors-market
Nocturia Market- https://www.delveinsight.com/report-store/nocturia-market
Obstructive Sleep Apnea Market- https://www.delveinsight.com/report-store/obstructive-sleep-apnea-osa-market
Phototherapies For Psoriasis Market- https://www.delveinsight.com/report-store/phototherapy-devices-market
Plaque Modification Devices Market- https://www.delveinsight.com/report-store/plaque-modification-devices-market
Polycystic Ovarian Syndrome Market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
Primary Mediastinal Large B-cell Lymphoma Market- https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
Rosacea Market - https://www.delveinsight.com/report-store/rosacea-market
Sarcopenia Market- https://www.delveinsight.com/report-store/sarcopenia-market
Testicular Neoplasm Market- https://www.delveinsight.com/report-store/testicular-neoplasm-market
Type 1 Diabetes Market- https://www.delveinsight.com/report-store/type-1-diabetes-market
Vascular Access Devices Market- https://www.delveinsight.com/report-store/vascular-access-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.